137 related articles for article (PubMed ID: 11208750)
1. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.
Black HR; Elliott WJ; Neaton JD; Grandits G; Grambsch P; Grimm RH; Hansson L; Lacoucière Y; Muller J; Sleight P; Weber MA; White WB; Williams G; Wittes J; Zanchetti A; Fakouhi TD; Anders RJ
Hypertension; 2001 Jan; 37(1):12-18. PubMed ID: 11208750
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Black HR; Elliott WJ; Neaton JD; Grandits G; Grambsch P; Grimm RH; Hansson L; Lacoucière Y; Muller J; Sleight P; Weber MA; White WB; Williams G; Wittes J; Zanchetti A; Fakouhi TD
Control Clin Trials; 1998 Aug; 19(4):370-90. PubMed ID: 9683312
[TBL] [Abstract][Full Text] [Related]
3. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
4. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
5. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; Neaton JD; Grimm RH; Hansson L; Lacourcière Y; Muller JE; Sleight P; Weber MA; White WB; Williams GH; Wittes J; Zanchetti A; Anders RJ;
J Hypertens; 2005 May; 23(5):1099-106. PubMed ID: 15834298
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
Neutel JM; Weber MA; Julius S; Cohn JN; Turlapaty P; Shen Y; Guo W; Batchelor A; Lagast H
Am J Cardiovasc Drugs; 2004; 4(5):335-41. PubMed ID: 15449975
[TBL] [Abstract][Full Text] [Related]
8. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
9. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
11. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.
White WB; Mehrotra DV; Black HR; Fakouhi TD
Am J Cardiol; 1997 Aug; 80(4):469-74. PubMed ID: 9285660
[TBL] [Abstract][Full Text] [Related]
12. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.
Egan BM; Zhao Y; Axon RN
JAMA; 2010 May; 303(20):2043-50. PubMed ID: 20501926
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
Banegas JR; Segura J; Ruilope LM; Luque M; García-Robles R; Campo C; Rodríguez-Artalejo F; Tamargo J;
Hypertension; 2004 Jun; 43(6):1338-44. PubMed ID: 15117908
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
15. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
17. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Cushman WC; Materson BJ; Williams DW; Reda DJ
Hypertension; 2001 Oct; 38(4):953-7. PubMed ID: 11641316
[TBL] [Abstract][Full Text] [Related]
19. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial.
He J; Irazola V; Mills KT; Poggio R; Beratarrechea A; Dolan J; Chen CS; Gibbons L; Krousel-Wood M; Bazzano LA; Nejamis A; Gulayin P; Santero M; Augustovski F; Chen J; Rubinstein A;
JAMA; 2017 Sep; 318(11):1016-1025. PubMed ID: 28975305
[TBL] [Abstract][Full Text] [Related]
20. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
